Eli Lilly
Last updated on 2017-10-25T12:07+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| major | 2.04% | EN | 25/10/2017 |
| general | 4.08% | EN | 07/09/2017 |
| manufacturer | 16.33% | EN | 28/08/2017 |
| farmacêutica | 4.08% | PT | 16/02/2017 |
| concurrent | 4.08% | FR | 31/01/2017 |
| rival | 46.94% | EN | 19/12/2016 |
| cio | 8.16% | EN | 12/12/2016 |
| competitor | 4.08% | EN | 09/12/2016 |
| inventor | 2.04% | EN | 13/10/2016 |
| farmacêutica americana | 8.16% | PT | 01/09/2016 |
| Names | Lang | Count |
|---|---|---|
| Eli Lilly | EN | 64.40% |
| Eli Lilly | FR | 12.12% |
| Eli Lilly | PT | 5.76% |
| Eli Lilly | ES | 4.96% |
| Eli Lilly | AF | 4.94% |
| Eli Lilly | HR | 4.94% |
| ELI LILLY | FR | 1.01% |
| Eli Lily | EN | 0.93% |
| ELI LILLY | EN | 0.36% |
| Eli Lilly | DE | 0.14% |
| Ely Lilly | EN | 0.11% |
| Eli Lily | FR | 0.11% |
| Eli Lilly | AR | 0.08% |
| Ely Lilly | FR | 0.08% |
| Ely Lilly | DE | 0.03% |
| Eli Lilly | DA | 0.03% |
| Eli Lilliy | NL | 0.00% |
| Ely Lily | EN | 0.00% |
| Elly Lily | NL | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 5.90% |
| GlaxoSmithKline | 3.73% |
| Drug Administration | 3.21% |
| Pfizer Inc | 2.69% |
| Reuters Group | 2.59% |
| GlaxoSmithKline Plc | 1.66% |
| World Health Organization | 1.66% |
| Novartis | 1.45% |
| Eisai Co | 1.24% |
 | Association | 1.24% |
| United Nations | 1.24% |
| Pharmaceuticals Inc | 1.14% |
| Roche Holding AG | 1.14% |
| Commission | 1.04% |
| European Union | 1.04% |
| Novo Nordisk | 0.93% |
| Swedish | 0.93% |
| Bristol Myers Squibb | 0.93% |
| Laura Wood | 0.93% |
| Washington University School | 0.93% |
| Johns Hopkins | 0.83% |
| SA | 0.83% |
| British | 0.83% |
| S government | 0.72% |
| Mayo Clinic | 0.72% |
| Boehringer Ingelheim | 0.72% |
| Caleb Alexander | 0.62% |
| Abbott Laboratories | 0.62% |
| Oxford University | 0.62% |
| Hong Kong Limited | 0.62% |
| Type | Entity Name | Score |
|---|---|---|
| Ramón Lorenzo | 0.0508 |
| GlaxoSmithKline | 0.0312 |
| Stephane Epelbaum | 0.0217 |
| Drug Administration | 0.0189 |
| GlaxoSmithKline Plc | 0.016 |
| Novartis | 0.0133 |
| VWR Corporation | 0.0122 |
| Eisai Co | 0.012 |
| Roche Holding AG | 0.0105 |
| Pharmaceuticals Inc | 0.0103 |
| Novo Nordisk | 0.0095 |
| Bristol Myers Squibb | 0.0091 |
| Washington University School | 0.0083 |
| Inc | 0.0076 |
| Laura Wood | 0.0074 |
| Swedish | 0.0069 |
| Boehringer Ingelheim | 0.0067 |
| Mayo Clinic | 0.0062 |
| Caleb Alexander | 0.006 |
| Hong Kong Limited | 0.006 |
| Kong Limited | 0.006 |
| Abbott Laboratories | 0.0057 |
| Five Forces | 0.0056 |
| Gerri Martin Flickinger | 0.0054 |
| Pfizer Inc | 0.0052 |
| Nature Medicine | 0.0052 |
| European Medicines Agency | 0.0051 |
| Medicines Agency | 0.0051 |
| Bill Berkrot | 0.0051 |
| Anderson Cancer | 0.0049 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Wednesday, January 19, 2022
4:37:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 